With no added sugar, this highly absorbable product is flavored by citrus fruit
As competition intensifies and new distribution models emerge, innovation across the obesity drug industry continues to accelerate
The contributions of GIP and glucagon receptor activation to bowel changes are not yet well characterised for retatrutide specifically, and any claims about their effects on gut motility or intestinal secretion remain uncertain given the medicine's investigational status
"But some GLP-1 drugs are less expensive or perhaps will be soon." Image: katiko-dp/Getty Images About the Author Maureen Salamon, Executive Editor, Harvard Women's Health Watch About the Reviewer Toni Golen, MD, Editor in Chief, Harvard Women's Health Watch
Wegovy has slightly higher doses than Ozempic because it is explicitly designed to promote weight loss
They also have realistic expectations